Clinical Trials Logo

Clinical Trial Summary

Creatine (methyl-d3) dilution (D3-creatine) is a novel technique for the estimation of muscle mass. The method uses a dose of deuterium-labelled creatine to determine total skeletal muscle mass via estimation of total body creatine pool size.The aim of this study is to compare estimates of total body skeletal muscle mass by D3-creatine dilution method and whole body Magnetic Resonance Imaging (MRI) in an athletic population.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT02519751
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT02112695 - Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study N/A
Not yet recruiting NCT05489666 - Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females N/A
Completed NCT04642144 - Effect of Infusion of Yerba Mate on Oxidative Stress, Physiology, and Performance of Trained Cyclists N/A
Completed NCT02458599 - Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise N/A
Completed NCT03083509 - A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types N/A